| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10800550 | Biochimica et Biophysica Acta (BBA) - General Subjects | 2013 | 9 Pages |
Abstract
PCI of CD133-targeting toxins may be used as a minimal invasive strategy in the treatment of sarcomas, and potentially as a therapeutic for other solid tumors expressing CD133.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Eva Wessel Stratford, Monica Bostad, Russell Castro, Ellen Skarpen, Kristian Berg, Anders Høgset, Ola Myklebost, Pål Kristian Selbo,